SMA Scoliosis Surgery denied as duplicate or overlapping therapy by Kaiser Permanente?

Kaiser Permanente's specific coverage criteria for sma scoliosis surgery are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Kaiser Denies Scoliosis Surgery for SMA as Duplicate Therapy — and Why This Is Appealable

A "duplicate therapy" denial in the context of scoliosis surgery for spinal muscular atrophy (SMA) typically occurs when Kaiser determines that another ongoing treatment — most commonly an approved SMA disease-modifying therapy — is already addressing the underlying condition, making the surgical intervention allegedly redundant. This rationale is clinically flawed in most SMA scoliosis cases: disease-modifying therapies address the neuromuscular disease itself but do not correct established, structural spinal curvature. Surgery and disease-modifying therapy serve distinct, non-overlapping clinical purposes, and treating one does not substitute for treating the other.

## The Federal Appeal Framework

• Internal appeal: File within the timeframe on your denial notice. Request Kaiser's complete clinical criteria for "duplicate therapy" in writing.
• External review (ACA §2719): After Kaiser upholds the denial internally, you have approximately 4 months (120 days) to request independent external review. An external reviewer with orthopedic and neuromuscular expertise will assess whether surgery and disease-modifying therapy truly duplicate each other clinically.
• Expedited review: If progressive curvature is compromising respiratory function or causing acute pain, request expedited review — Kaiser must respond within 72 hours.
• ERISA §503: Entitles you to every document Kaiser used to classify the surgery as duplicative.

## What to Gather

1. Distinct clinical purpose documentation — orthopedic and neuromuscular specialist notes explicitly explaining that scoliosis surgery addresses structural deformity while disease-modifying therapy addresses neuromuscular disease — they are not interchangeable. 2. Imaging — spinal X-rays, MRI, or CT demonstrating the degree of curvature and its structural, irreversible nature. 3. Functional impact documentation — records showing respiratory compromise, pain, positioning difficulty, or quality-of-life effects directly attributable to the scoliosis rather than the neuromuscular disease alone. 4. Prescriber medical-necessity letter — from both the orthopedic surgeon and the neuromuscular specialist, clarifying the distinct goals of each treatment. 5. Applicable surgical guidelines — your surgeon should reference the relevant spine surgery or SMA management guideline organization that supports surgery for structural scoliosis even in patients receiving disease-modifying therapy.

## Criteria-Mapping Structure

Obtain Kaiser's duplicate-therapy policy criteria and respond point by point:

| Kaiser's Duplicate-Therapy Assertion | Your Rebuttal Evidence | |---|---| | Existing therapy already treats the condition | Specialist letter distinguishing structural vs. neuromuscular targets | | Surgery serves the same clinical purpose | Imaging + orthopedic note on surgical goals | | No independent medical necessity for surgery | Functional assessment showing scoliosis-specific impairment |

The appeal's central argument: scoliosis surgery and SMA disease-modifying therapy have non-overlapping indications and mechanisms. Coverage of one does not fulfill the medical necessity for the other.